PK-PD modeling of irbesartan in healthy Chinese adult volunteers under non-steady-state conditions-Reference-Cited by-同舟云学术

PK-PD modeling of irbesartan in healthy Chinese adult volunteers under non-steady-state conditions

Published:2006-12 Issue:4 Volume:31 Page:259-264
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:European Journal of Drug Metabolism and Pharmacokinetics

Author:

Huang Xiao-Hui,Li Jun,Qiu Fu-Rong,Xie Hai-Tang,Huang Ji-Han,Li Jian-Chun,Zheng Qing-Shan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF03190465.pdf

Reference16 articles.

1. Waeber B. (2001 ): A review of irbesartan in antihypertensive therapy: comparison with other antihypertensive agents. Curr. Ther. Res. 62, 505–521.

2. Mao G.G. Chen B. Sun H. et al (2001): Relative bioavailability of irbesartan capsules in healthy volunteers. Chin. J. Clin. Pharmacol. 17, 207–209.

3. Vachharajani N.N. Shyu W.C. et at (1998): Oral bioavailability and disposition characteristics of irbesartan, an angiotensin antagonist, in healthy volunteers. J. Clin. Pharmacol. 38, 702–707.

4. Ismail Z. Triggs E.J. Smithurst B. A. et al (1989): The pharmacokinetics of amiloride hydrochlorothiazide combination in the young and elderly. Eur. J. Clin. Pharmacol. 37, 167–171.

5. Huang XH, Qiu FR, Xie HT, et al (2005): Pharmacokinetic and pharmacodynamic of irbesartan in renal hypertensive dogs under non-steady-state and steady-state conditions. Eur. J. Drug. Metab Pharmacokinet. 30, 121–125.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes;Archives of Pharmacal Research;2023-12

2. Delay differential equations for the description of Irbesartan pharmacokinetics: A population approach to model absorption complexities leading to dual peaks;European Journal of Pharmaceutical Sciences;2020-10

3. COMPARATIVE RANDOMIZED, SINGLE DOSE, TWO-WAY CROSSOVER, OPEN-LABEL STUDY TO DETERMINE THE BIOEQUIVALENCE OF IRBESARTAN FORMULATION, IRBESARTAN GPO 150 MG TABLETS AND APROVEL (R) 150 MG TABLETS, AFTER ORAL ADMINISTRATION TO HEALTHY THAI VOLUNTEERS UNDER FASTING CONDITIONS;J HEALTH RES;2016

4. The pharmacokinetic-pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long-term administration in spontaneously hypertensive rats;Fundamental & Clinical Pharmacology;2015-10-05

5. Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects;Biopharmaceutics & Drug Disposition;2015-02-04